Topotecan Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 16729-151

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topotecan Hydrochloride (NDC 16729-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topotecan Hydrochloride Chemical Structure (Topotecan Image1)

Chemical structure diagram illustrating the molecular composition of topotecan hydrochloride, showing its atomic connections and arrangement.*

FDA Label Image

Figure 1. Kaplan-meier Curves For Overall Survival In Cervical Cancer In Study Gog 0179 (Topotecan Image2)

A survival curve chart comparing proportion surviving over months on study for Topotecan Hydrochloride for Injection plus Cisplatin versus Cisplatin Monotherapy. The solid line represents Topotecan plus Cisplatin, and the dashed line represents Cisplatin Monotherapy. A table below the chart shows the number at risk over time for each treatment group up to 40 months.*

FDA Label Image

Topotecan Injection Label (Topotecan Image3)

Label for topotecan hydrochloride injection, powder, lyophilized, for solution, 4 mg per vial. The label indicates intravenous use, prescription only status, and highlights that it must be reconstituted. Manufactured by Accord Healthcare, Inc., with reference to additional manufacturing by Intas Pharmaceuticals Limited in India. The label includes storage instructions, safety handling precautions, and notes on cytotoxicity and active ingredient composition.*

FDA Label Image

Topotecan Injection Label (Topotecan Image4)

Packaging carton label for Topotecan Hydrochloride injection, powder, lyophilized, for intravenous use. Each vial contains 4 mg per vial. Label shows manufacture by Intas Pharmaceuticals Limited and labeling by Accord Healthcare, Inc. The label includes storage instructions, handling precautions, and indicates the product is Rx only and single-dose vial.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.